In summary, we showed that Ly, a third-generation MR blocker, is superior to Eple as an antihypertensive, antiproteinuric and renoprotective agent in the Nx model, without aggravating hyperkalemia. This evidence concerns the gene NR3C2 and Hyperkalemia.